Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Faron Pharmaceuticals Oy

FARN
187,50
-5,00 (-2,60%)
Ultimo aggiornamento: 09:44:38
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
13/12/202408:00LSEG_RNSFaron Pharmaceuticals Oy Faron’s Financial Calendar for 2025
10/12/202415:31ALNCNewsIN BRIEF: Faron Pharmaceuticals shares up as presents data..
10/12/202408:47PRNUSFaron presents BEXMAB data at ASH Annual Meeting
10/12/202408:00LSEG_NONFaron Pharmaceuticals Oy Faron presents BEXMAB data at ASH..
02/12/202409:00LSEG_NONFaron Pharmaceuticals Oy Interactions with UK Regulatory..
27/11/202412:29ALNCNewsFaron announces promising findings from blood cancer drug..
27/11/202408:00LSEG_RNSFaron Pharmaceuticals Oy Positive Phase 2 Interim Results..
11/11/202408:00LSEG_NONFaron Pharmaceuticals Oy Targeting Soluble Clever-1 for..
05/11/202408:00LSEG_RNSFaron Pharmaceuticals Oy Shareholders’ Nomination Board
22/10/202408:00LSEG_RNSFaron Pharmaceuticals Oy Faron’s Capital Markets Day 2024
07/10/202408:00LSEG_NONFaron Pharmaceuticals Oy Faron announces Capital Markets Day
30/8/202408:00LSEG_RNSFaron Pharmaceuticals Oy Grant of options
27/8/202412:08ALNCNewsFaron Pharma shares surge as US FDA grants fast track..
27/8/202408:00LSEG_RNSFaron Pharmaceuticals Oy FDA Grants Fast Track Designation..
27/8/202408:00LSEG_RNSFaron Pharmaceuticals Oy Faron 2024 Half-Year Financial..
20/8/202408:00LSEG_RNSFaron Pharmaceuticals Oy Notice of Half-Year Financial..
13/8/202414:23ALNCNewsIN BRIEF: Faron Pharmaceuticals joins US grant for..
13/8/202408:00LSEG_NONFaron Pharmaceuticals Oy Traumakine Research Collaboration..
12/8/202413:01ALNCNewsEXECUTIVE CHANGES: New chief executives at Cornish Metals..
08/8/202408:00LSEG_RNSFaron Pharmaceuticals Oy Appointment of Chief Financial..
07/8/202411:00LSEG_RNSFaron Pharmaceuticals Oy Grant of options
06/8/202417:51ALNCNewsIN BRIEF: Faron Pharmaceuticals names Petri Bono as CMO
06/8/202409:30LSEG_RNSFaron Pharmaceuticals Oy Faron Appoints Dr. Petri Bono as..
11/7/202420:23ALNCNewsTRADING UPDATES: Titon warns on trading; Videndum revenue..
11/7/202408:00LSEG_RNSFaron Pharmaceuticals Oy Faron Announces Positive FDA..
25/6/202415:00LSEG_RNSFaron Pharmaceuticals Oy Update on settlement
25/6/202411:30LSEG_RNSFaron Pharmaceuticals Oy Holding(s) in Company - Replacement
24/6/202413:45LSEG_RNSFaron Pharmaceuticals Oy Holding(s) in Company
24/6/202413:45LSEG_RNSFaron Pharmaceuticals Oy Holding(s) in Company
24/6/202413:45LSEG_RNSFaron Pharmaceuticals Oy Holding(s) in Company
24/6/202413:45LSEG_RNSFaron Pharmaceuticals Oy Holding(s) in Company
20/6/202414:00LSEG_RNSFaron Pharmaceuticals Oy New shares registered with Finnish..
20/6/202408:00LSEG_RNSFaron Pharmaceuticals Oy Fully subscribed EUR 30.7 million..
05/6/202409:00LSEG_RNSFaron Pharmaceuticals Oy Proposed REX Retail Offer
04/6/202408:00LSEG_RNSFaron Pharmaceuticals Oy Faron commences a share offering
20/5/202410:03ALNCNewsFaron Pharma celebrates positive read-out in ongoing MDS..
20/5/202408:00LSEG_RNSFaron Pharmaceuticals Oy Initial positive data from Phase 2..
17/5/202417:00LSEG_RNSFaron Pharmaceuticals Oy Issuance of warrants
16/5/202408:05LSEG_NONFaron Pharmaceuticals Oy Founders named European Inventor..
13/5/202408:00LSEG_RNSFaron Pharmaceuticals Oy Replacement – Board Change
03/5/202414:39ALNCNewsTRADING UPDATES: Kelso raises stake in NCC; Transense joins..
30/4/202415:00LSEG_RNSFaron Pharmaceuticals Oy Update on financial status
30/4/202414:00LSEG_RNSFaron Pharmaceuticals Oy Board Change
16/4/202408:00LSEG_NONFaron Pharmaceuticals Oy Faron confirms plans under new..
15/4/202411:58ALNCNewsFaron Pharmaceuticals reappoints former finance chief on..
15/4/202408:00LSEG_RNSFaron Pharmaceuticals Oy Appointment of Chief Financial..
08/4/202412:50ALNCNewsUPDATE: Faron Pharmaceuticals promotes COO to CEO as father..
08/4/202412:28ALNCNewsFaron Pharmaceuticals promotes COO to CEO as founder steps..
08/4/202408:15ALNCNews*Faron Pharmaceuticals says Markku Jalkanen to retire as CEO..
08/4/202408:10LSEG_RNSFaron Pharmaceuticals Oy Approval of Warrant Terms and..
Apertura: 192,50 Min: 185,00 Max: 192,50
Chiusura: 192,50

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network